NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521,014 | +3.4% | 5,115 | +2.4% | 0.33% | +17.2% |
| Q2 2023 | $503,844 | +9.5% | 4,993 | -0.2% | 0.28% | +4.4% |
| Q1 2023 | $460,184 | +3.8% | 5,002 | +2.4% | 0.27% | +2.6% |
| Q4 2022 | $443,349 | -6.7% | 4,887 | -21.8% | 0.27% | -15.8% |
| Q3 2022 | $475,000 | -18.5% | 6,249 | -9.4% | 0.32% | -17.7% |
| Q2 2022 | $583,000 | -7.6% | 6,896 | -4.0% | 0.38% | +4.1% |
| Q1 2022 | $631,000 | -2.9% | 7,186 | -3.4% | 0.37% | +0.3% |
| Q4 2021 | $650,000 | -19.9% | 7,436 | -25.0% | 0.37% | -29.0% |
| Q3 2021 | $811,000 | -7.4% | 9,921 | +3.3% | 0.52% | -8.3% |
| Q2 2021 | $876,000 | -24.9% | 9,603 | -22.3% | 0.56% | -33.0% |
| Q4 2020 | $1,166,000 | +9.9% | 12,353 | +1.2% | 0.84% | +0.4% |
| Q3 2020 | $1,061,000 | +4.3% | 12,204 | +4.8% | 0.84% | -1.8% |
| Q2 2020 | $1,017,000 | +8.7% | 11,647 | +2.6% | 0.86% | -10.6% |
| Q1 2020 | $936,000 | -15.6% | 11,352 | -3.1% | 0.96% | +5.9% |
| Q4 2019 | $1,109,000 | +8.3% | 11,712 | -0.6% | 0.90% | +1.2% |
| Q3 2019 | $1,024,000 | -12.3% | 11,787 | -7.8% | 0.89% | -10.5% |
| Q2 2019 | $1,168,000 | -3.0% | 12,791 | +2.2% | 1.00% | -4.9% |
| Q1 2019 | $1,204,000 | +9.9% | 12,520 | -2.0% | 1.05% | -3.9% |
| Q4 2018 | $1,096,000 | +0.2% | 12,770 | +0.6% | 1.09% | +15.0% |
| Q3 2018 | $1,094,000 | +13.1% | 12,695 | -0.8% | 0.95% | +3.9% |
| Q2 2018 | $967,000 | -6.9% | 12,795 | -0.4% | 0.91% | -8.5% |
| Q1 2018 | $1,039,000 | -6.3% | 12,845 | -2.7% | 1.00% | +2.8% |
| Q4 2017 | $1,109,000 | -0.3% | 13,205 | +2.0% | 0.97% | -5.4% |
| Q3 2017 | $1,112,000 | +11.9% | 12,950 | +8.8% | 1.02% | +9.6% |
| Q2 2017 | $994,000 | +17.8% | 11,905 | +4.8% | 0.94% | +16.9% |
| Q1 2017 | $844,000 | +0.7% | 11,362 | -1.3% | 0.80% | -2.0% |
| Q4 2016 | $838,000 | -40.3% | 11,510 | -24.7% | 0.82% | -51.1% |
| Q3 2015 | $1,404,000 | -1.7% | 15,282 | +5.2% | 1.67% | +2.9% |
| Q2 2015 | $1,428,000 | +1.0% | 14,522 | +1.2% | 1.62% | +10.8% |
| Q1 2015 | $1,414,000 | +15.7% | 14,348 | +8.8% | 1.46% | +16.5% |
| Q4 2014 | $1,222,000 | – | 13,188 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |